Cargando…

Primary hyperparathyroidism associated with vitamin D toxicity in a patient with severe osteoporosis receiving teriparatide

Detalles Bibliográficos
Autores principales:	Gupta, Vishal, Patil, Sudarshan, Shah, Dhiren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2012
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3475930/ https://www.ncbi.nlm.nih.gov/pubmed/23087890 http://dx.doi.org/10.4103/2230-8210.100697

Ejemplares similares

Normocalcemic primary hyperparathyroidism in a patient with severe osteoporosis receiving teriparatide
por: Gupta, Vishal
Publicado: (2013)

Teriparatide – Indications beyond osteoporosis
por: Cheng, Marilyn Lee, et al.
Publicado: (2012)

Teriparatide in the management of osteoporosis
por: Bodenner, Donald, et al.
Publicado: (2007)

Symptomatic primary hyperparathyroidism in Indians
por: Kamalanathan, Sadishkumar C., et al.
Publicado: (2011)

Primary hyperparathyroidism in a child
por: Al-Mendalawi, M. D.
Publicado: (2015)

Incidentally Detected Primary Hyperparathyroidism
por: Saran, Sonal, et al.
Publicado: (2020)

Therapy of Osteoporosis in Men with Teriparatide
por: Cusano, Natalie E., et al.
Publicado: (2011)

Effects of 12-months treatment with zoledronate or teriparatide on intima-media thickness of carotid artery in women with postmenopausal osteoporosis: A pilot study
por: Passeri, Elena, et al.
Publicado: (2019)

Surgical management of primary hyperparathyroidism in Canada
por: Williams, Blair A, et al.
Publicado: (2014)

Once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis: reply to T. Kawada
por: Sugimoto, T., et al.
Publicado: (2014)

Combined treatment of vitamin K and teriparatide on bone metabolism and biomechanics in rats with osteoporosis
por: Huang, Youqing
Publicado: (2018)

Unmasking of primary hyperparathyroidism by Vitamin D therapy
por: Bala, S., et al.
Publicado: (2015)

Profile of teriparatide in the management of postmenopausal osteoporosis
por: Sikon, Andrea, et al.
Publicado: (2010)

Teriparatide for osteoporosis: importance of the full course
por: Lindsay, R., et al.
Publicado: (2016)

Treatment of osteoporosis with teriparatide: The Slovenian experience
por: Kocjan, Tomaz, et al.
Publicado: (2021)

Primary hyperparathyroidism due to mediastinal parathyroid lesions
por: Gawrychowski, Jacek, et al.
Publicado: (2021)

Teriparatide treatment for postmenopausal women with sacral insufficiency fracture
por: Kim, Young-Hoon
Publicado: (2023)

Teriparatide in the Treatment of Severe Postmenopausal Osteoporosis: A Cost-Utility Analysis
por: Taheri, Saeed, et al.
Publicado: (2019)

THU441 Teriparatide As Treatment For Severe Osteoporosis In Lung Transplant Recipients
por: Muir, Christopher Alan, et al.
Publicado: (2023)

Primary hyperparathyroidism and malignancy: Forgotten friends or new aquaintances
por: Chatterjee, Krishnarpan, et al.
Publicado: (2014)

Multiple endocrine neoplasia and primary hyperparathyroidism – practical approach
por: Koza, Jarosław
Publicado: (2015)

Primary hyperparathyroidism in a case of chronic myelogenous leukemia
por: Valizadeh, Nasim, et al.
Publicado: (2013)

Improvement in polycythaemia vera after parathyroidectomy for primary hyperparathyroidism
por: Sthaneshwar, Pavai, et al.
Publicado: (2022)

Reply on “teriparatide treatment for postmenopausal women with sacral insufficiency fracture”
por: Yang, Yao-Chun, et al.
Publicado: (2023)

Management of glucocorticoids-induced osteoporosis: role of teriparatide
por: Migliaccio, Silvia, et al.
Publicado: (2009)

Role of teriparatide in treatment of glucocorticoid-induced osteoporosis
por: Lau, Arthur N, et al.
Publicado: (2010)

A Case of Teriparatide on Pregnancy-Induced Osteoporosis
por: Lee, Seok Hong, et al.
Publicado: (2013)

Update on the safety and efficacy of teriparatide in the treatment of osteoporosis
por: Minisola, Salvatore, et al.
Publicado: (2019)

Denosumab as a Bridge to Surgery in a Patient with Severe Hypercalcemia Due to Primary Hyperparathyroidism in the Setting of Renal Dysfunction
por: Rajan, Remya, et al.
Publicado: (2019)

Sarcoidosis and primary hyperparathyroidism simultaneously occurring in a hypercalcemic patient
por: Hassan, Syed, et al.
Publicado: (2012)

Reversible Parkinsonism Due to Vitamin D Toxicity
por: Chatterjee, Rudrarpan, et al.
Publicado: (2017)

Osteoporosis awareness among primary care physicians in Malaysia
por: Gupta, Esha Das, et al.
Publicado: (2013)

Vitamin D toxicity presenting with altered sensorium and hypercalcaemia
por: Sarma, Anuj
Publicado: (2020)

Treatment responses with once-weekly teriparatide therapy for osteoporosis
por: Shiraki, M., et al.
Publicado: (2016)

Pituitary apoplexy presenting as myocardial infarction
por: Gupta, Vishal, et al.
Publicado: (2014)

Weekly Teriparatide Therapy Rapidly Accelerates Bone Healing in Pyogenic Spondylitis with Severe Osteoporosis
por: Shinohara, Akira, et al.
Publicado: (2014)

Teriparatide treatment in severe osteoporosis – a controlled 10-year follow-up study
por: Kontogeorgos, Georgios, et al.
Publicado: (2022)

Vitamin D Deficiency in Critically Ill
por: Angurana, Suresh Kumar, et al.
Publicado: (2017)

Persistent Primary Hyperparathyroidism, Severe Vitamin D Deficiency, and Multiple Pathological Fractures
por: Mendoza-Zubieta, Victoria, et al.
Publicado: (2016)

Hyperparathyroidism in dentistry: Issues and challenges!!
por: Khalekar, Yogita, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_tpdge5quuam4ad893kqk4j5v5e